the staff of the Ridgewood blog
Ridgewood NJ, Cognito Therapeutics Inc. will soon be conducting late-stage trials of a device for treating Alzheimer’s disease. The trial will involve around 500 US participants wearing a headset for an hour a day over a year. The headset delivers light and sound at a frequency that improves cognitive ability. If Cognito’s headset proves effective, it could see wide adoption in 2024.
Continue reading FDA Gives Cognito Therapeutics Breakthrough Status on it’s Alzheimer Headset
